B. Riley Wealth Advisors Inc. Sells 2,417 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

B. Riley Wealth Advisors Inc. lowered its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 20.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 9,209 shares of the company’s stock after selling 2,417 shares during the quarter. B. Riley Wealth Advisors Inc.’s holdings in GE HealthCare Technologies were worth $850,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in GEHC. Retirement Systems of Alabama grew its holdings in GE HealthCare Technologies by 7.3% during the 3rd quarter. Retirement Systems of Alabama now owns 100,505 shares of the company’s stock worth $9,432,000 after acquiring an additional 6,862 shares during the last quarter. Tidal Investments LLC grew its stake in shares of GE HealthCare Technologies by 32.5% during the third quarter. Tidal Investments LLC now owns 23,715 shares of the company’s stock valued at $2,226,000 after purchasing an additional 5,819 shares during the last quarter. Wilmington Savings Fund Society FSB increased its holdings in shares of GE HealthCare Technologies by 150.2% in the third quarter. Wilmington Savings Fund Society FSB now owns 11,278 shares of the company’s stock valued at $1,058,000 after purchasing an additional 6,770 shares in the last quarter. World Investment Advisors LLC raised its position in GE HealthCare Technologies by 44.5% in the 3rd quarter. World Investment Advisors LLC now owns 4,716 shares of the company’s stock worth $443,000 after purchasing an additional 1,453 shares during the last quarter. Finally, Sanctuary Advisors LLC lifted its holdings in GE HealthCare Technologies by 29.6% during the 3rd quarter. Sanctuary Advisors LLC now owns 20,761 shares of the company’s stock worth $1,948,000 after buying an additional 4,738 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Down 1.3 %

NASDAQ GEHC opened at $79.25 on Wednesday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The stock’s 50-day moving average is $85.41 and its 200-day moving average is $83.80. GE HealthCare Technologies Inc. has a one year low of $71.31 and a one year high of $94.55. The firm has a market cap of $36.21 billion, a P/E ratio of 21.77, a P/E/G ratio of 2.96 and a beta of 1.07.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.06 by $0.08. The firm had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business’s revenue was up .9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.99 earnings per share. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be paid a $0.035 dividend. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 annualized dividend and a yield of 0.18%. GE HealthCare Technologies’s payout ratio is presently 3.85%.

Insiders Place Their Bets

In other news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders own 0.27% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on GEHC. Stifel Nicolaus lifted their target price on GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research note on Monday, September 30th. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research note on Wednesday, September 18th. Evercore ISI boosted their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 1st. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and reduced their price objective for the company from $84.00 to $74.00 in a research note on Thursday, September 26th. Finally, Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One equities research analyst has rated the stock with a sell rating, four have given a hold rating, eight have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $95.46.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.